Matches in SemOpenAlex for { <https://semopenalex.org/work/W50240922> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W50240922 endingPage "7" @default.
- W50240922 startingPage "1061" @default.
- W50240922 abstract "It was our aim to study the prevalence and possible prognostic and predictive significance of the expression of P-glycoprotein, a transmembrane transport protein related to classical multidrug resistance, in patients with advanced ovarian cancer.Tumor tissue from 73 previously untreated patients with FIGO stage 3 ovarian cancer was examined with immunohistochemistry for the expression of P-glycoprotein before and after chemotherapy. Response to 4 cycles of combination chemotherapy with cisplatin and epirubicin was assessed with second look laparotomy. The log rank test was used for univariate survival and the Cox proportional hazards regression model for multivariate survival analysis.P-glycoprotein expression was detected in 47% of untreated cases, and correlated with unfavourable prognostic factors such as advanced age, presence of ascites and larger residual disease deposits after primary surgery. P-glycoprotein negative cases responded significantly better to chemotherapy (P < .001). In the multivariate survival analysis P-glycoprotein expression was an independent predictor of both overall (P = .045) and progression free (P = .006) survival. When P-glycoprotein expression and residual disease status were considered together, the patients could be divided in three clearly distinct prognostic groups (P = .0009).P-glycoprotein expression is a predictor of response and survival in a uniformly treated and followed cohort of advanced ovarian cancer patients." @default.
- W50240922 created "2016-06-24" @default.
- W50240922 creator A5010825300 @default.
- W50240922 creator A5018546041 @default.
- W50240922 creator A5029968097 @default.
- W50240922 creator A5044526822 @default.
- W50240922 creator A5050991817 @default.
- W50240922 date "2000-05-16" @default.
- W50240922 modified "2023-10-08" @default.
- W50240922 title "P-glycoprotein expression is a marker for chemotherapy resistance and prognosis in advanced ovarian cancer." @default.
- W50240922 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10810398" @default.
- W50240922 hasPublicationYear "2000" @default.
- W50240922 type Work @default.
- W50240922 sameAs 50240922 @default.
- W50240922 citedByCount "31" @default.
- W50240922 countsByYear W502409222013 @default.
- W50240922 countsByYear W502409222014 @default.
- W50240922 countsByYear W502409222015 @default.
- W50240922 countsByYear W502409222016 @default.
- W50240922 countsByYear W502409222017 @default.
- W50240922 countsByYear W502409222019 @default.
- W50240922 countsByYear W502409222020 @default.
- W50240922 countsByYear W502409222022 @default.
- W50240922 crossrefType "journal-article" @default.
- W50240922 hasAuthorship W50240922A5010825300 @default.
- W50240922 hasAuthorship W50240922A5018546041 @default.
- W50240922 hasAuthorship W50240922A5029968097 @default.
- W50240922 hasAuthorship W50240922A5044526822 @default.
- W50240922 hasAuthorship W50240922A5050991817 @default.
- W50240922 hasConcept C10515644 @default.
- W50240922 hasConcept C114851261 @default.
- W50240922 hasConcept C121608353 @default.
- W50240922 hasConcept C126322002 @default.
- W50240922 hasConcept C133936738 @default.
- W50240922 hasConcept C143998085 @default.
- W50240922 hasConcept C146357865 @default.
- W50240922 hasConcept C151730666 @default.
- W50240922 hasConcept C204232928 @default.
- W50240922 hasConcept C2776694085 @default.
- W50240922 hasConcept C2776755627 @default.
- W50240922 hasConcept C2778239845 @default.
- W50240922 hasConcept C2778707650 @default.
- W50240922 hasConcept C2780427987 @default.
- W50240922 hasConcept C2780496750 @default.
- W50240922 hasConcept C2780835546 @default.
- W50240922 hasConcept C50382708 @default.
- W50240922 hasConcept C71924100 @default.
- W50240922 hasConcept C86803240 @default.
- W50240922 hasConcept C89423630 @default.
- W50240922 hasConceptScore W50240922C10515644 @default.
- W50240922 hasConceptScore W50240922C114851261 @default.
- W50240922 hasConceptScore W50240922C121608353 @default.
- W50240922 hasConceptScore W50240922C126322002 @default.
- W50240922 hasConceptScore W50240922C133936738 @default.
- W50240922 hasConceptScore W50240922C143998085 @default.
- W50240922 hasConceptScore W50240922C146357865 @default.
- W50240922 hasConceptScore W50240922C151730666 @default.
- W50240922 hasConceptScore W50240922C204232928 @default.
- W50240922 hasConceptScore W50240922C2776694085 @default.
- W50240922 hasConceptScore W50240922C2776755627 @default.
- W50240922 hasConceptScore W50240922C2778239845 @default.
- W50240922 hasConceptScore W50240922C2778707650 @default.
- W50240922 hasConceptScore W50240922C2780427987 @default.
- W50240922 hasConceptScore W50240922C2780496750 @default.
- W50240922 hasConceptScore W50240922C2780835546 @default.
- W50240922 hasConceptScore W50240922C50382708 @default.
- W50240922 hasConceptScore W50240922C71924100 @default.
- W50240922 hasConceptScore W50240922C86803240 @default.
- W50240922 hasConceptScore W50240922C89423630 @default.
- W50240922 hasIssue "2B" @default.
- W50240922 hasLocation W502409221 @default.
- W50240922 hasOpenAccess W50240922 @default.
- W50240922 hasPrimaryLocation W502409221 @default.
- W50240922 hasRelatedWork W1978495791 @default.
- W50240922 hasRelatedWork W2060155773 @default.
- W50240922 hasRelatedWork W2079646315 @default.
- W50240922 hasRelatedWork W2149063600 @default.
- W50240922 hasRelatedWork W2348623855 @default.
- W50240922 hasRelatedWork W2463572748 @default.
- W50240922 hasRelatedWork W2530877275 @default.
- W50240922 hasRelatedWork W4214690187 @default.
- W50240922 hasRelatedWork W50240922 @default.
- W50240922 hasRelatedWork W2226580565 @default.
- W50240922 hasVolume "20" @default.
- W50240922 isParatext "false" @default.
- W50240922 isRetracted "false" @default.
- W50240922 magId "50240922" @default.
- W50240922 workType "article" @default.